Recombinant adeno-associated virus (rAAV) is widely used in retinal gene therapy. Enhanced rAAV transduction may be important for better therapeutic effects in some retinal gene therapies. In this study, we examined the effects of adenovirus 5 (Ad5) on retina transduction mediated by rAAV2. Our results provide the first evidence that low levels of either replication-incompetent or conditional replication-competent Ad5 significantly enhance and accelerate transgene expression in human and rat retinal cells. This effect occurs principally at the transcriptional level, rather than through enhanced viral entry or DNA replication. In in vivo analyses with the SD rat, the Balb/c mouse, and the RCS rat, strong enhancement and acceleration of transgene expression, as well as therapeutic effects, were confirmed. Low levels of Ad5 may enhance the utility of rAAV2-mediated transduction strategies in future clinical investigations.
Introduction
Retinal degenerative diseases, such as age-related macular degeneration and retinitis pigmentosa, have become the leading causes of blindness in adults. (Porta & Bandello, 2002; Rodriguez et al., 2002) . There is currently no effective treatment available (Anonymous, 1991) . The eye is easily accessible and allows for local application of therapeutic vectors with a reduced risk of systemic effects. Accordingly, gene therapy represents an attractive approach in dealing with these inherited and acquired retinal disorders (Acland et al., 2005; Pang et al., 2004; .
Recombinant adeno-associated virus (rAAV) has been of considerable interest to developers of retinal gene therapies (Alexander et al., 2007; Auricchio, 2003; Bainbridge et al., 2003; Pang, Chang, et al., 2006; Pang et al., 2008) . Unlike adenoviruses, the introduction of rAAV vectors has not induced significant inflammation either experimentally or clinically because these vectors contain no viral genes. Furthermore, infection with rAAV has not been associated with any human disease (Muzyczka, 1992) . However, the transduction of rAAV occurs with relatively low efficiency in some tissues, which limits its therapeutic effects (Eslami et al., 2000; Vermeij et al., 2001; Zhang et al., 2008) . Increasing rAAV transduction should produce better therapeutic effects. Indeed, early studies reported that AAV2 can replicate and assemble in cells treated with hydroxyurea, UV or ionizing irradiation (Alexander, Russell, & Miller, 1994) . Several previous studies have sought to enhance rAAV-mediated transduction of tumor cells by applying chemical and physical agents such as c-rays, HDAC inhibitors and topoisomerase inhibitors (Kanazawa et al., 2003 (Kanazawa et al., , 2004 Kitazono, Goldsmith, Aikou, Bates, & Fojo, 2001 ). Originally, it was thought that all of these agents, except HDAC inhibitors, acted by a similar mechanism involving the conversion of AAV single-stranded DNA into double-stranded forms. HDAC inhibitors, however, might improve tumor cell transduction by enhancing the acetylation of the histone-associated chromatin of the rAAV genome.
An alternative approach for improving rAAV-mediated transduction may be provided by adenovirus. Ad (E4orf6)-enhanced rAAV gene expression is mainly due to the increased conversion of single-stranded rAAV2 genomes into double-stranded transcriptionally active forms. Adenovirus type 5 had been shown to increase the transduction efficiency of AAV in vitro in 293 and tumor cell cultures (Ferrari, Samulski, Shenk, & Samulski, 1996; Fisher et al., 1996) . Recently, researchers reported that the combination of AAV-BMP2 and Ad-BMP2 produces enhanced osteogenic activity in immunocompetent rats (Chen et al., 2004) . However, no study has directly investigated the effects of Ad5 on rAAV2-mediated gene expression in retinal cells. In this report, our results provide the first evidence that low-level Ad5 not only dramatically enhances, but also accelerates, transduction of rAAV2 vectors in retina in vitro and in vivo, with no remarkable apoptosis or immune response. This effect occurs principally at the transcriptional level, rather than through enhanced viral entry or DNA replication. Furthermore, we found that the enhancement effect of Ad5 on rAAV2 gene expression lasts for a long time after Ad5 has been eliminated from the retina.
Methods

Virus and cells
Conditional replication-competent adenovirus Ad5-TERT-E1A/E1B and replication-incompetent adenovirus Ad5-RFP were constructed and preserved by our experimental lab (Huang, Zhang, et al., 2004; Huang, Lin, et al., 2004) . These constructs were derived from the first-generation E1/E3-deleted adenovirus vector. AdNull (adenoviral type 5 vector backbone without cDNA insert) and the recombinant adeno-associated viral vectors rAAV2-GFP (green fluorescent protein gene), rAAV2-Luc (luciferase gene), and rAAV2-CNTF (ciliary neurotrophic factor gene) were purchased from Vector Gene Technology Company Limited (Beijing, China) (Gao et al., 2000) . Ad5-RFP, rAAV2-GFP, rAAV2-Luc, and rAAV2-CNTF express transgene under control of the CMV promoter. Ad5-TERT-E1A/E1B expresses E1A/E1B under the control of telomerase.
Human adult retinal pigmented epithelium (RPE) cells were obtained from adult eyes donated for corneal transplantation. Rat neural retinal cells were obtained from eyes of a 1-week-old SD rat. Isolation and primary culture were performed as previously described (Stramm, Haskins, McGovern, & Aguirre, 1983) . The established human RPE cell line APRE-19 (ATCC, Rockville, MD), and primary cultured human and rat retinal cells were grown in Dulbecco's modified Eagle's medium/F12 (Gibco, Grand Island, NY, USA) supplemented with 15% fetal bovine serum at 37°C, 5% CO 2 .
In vitro infection and transgene expression
APRE-19 cells, primary cultured rat neural retinal cells, and primary cultured RPE cells were seeded into 24-well plates at 1 Â 10 5 cells/well, and incubated in 500 ll growth medium for 24 h prior to infection. These cells were infected by rAAV2-GFP alone or in combination with Ad5-TERT-E1A/E1B, Ad5-RFP or AdNull. rAAV2-GFP was at 1000 and 10,000 vector genomes per cell (vg/cell). The combined adenoviruses included Ad5-RFP, AdNull, and Ad5-TERT-E1A/E1B at a multiplicity of infection (MOI) of 0.01, 0.1, 1, and 10 plaque-forming units per cell (PFU/cell), respectively. Here, we used different MOIs of AdNull and Ad5-TERT in order to find the best dose to enhance the GFP expression mediated by rAAV2. The uninfected cells were used as controls. GFP expression was imaged and recorded using inverted fluorescence microscopy (Zeiss Axio 100, Jena, Germany) every 24 h post-infection. Apoptosis and GFP expression of the infected APRE-19 cells were quantitatively examined by FACS (EPICS XL, Beckman Coulter Company, Miami, FL, USA) analysis. Propidium iodide (PI, Invitrogen, Carlsbad, CA, USA) was used for apoptosis evaluation.
mRNA analysis of transgene GFP and receptors for the AAV2
Total RNA was isolated from the APRE-19 cells 24, 72, and 120 h after infection with either rAAV2-GFP (10 4 vg/cell) alone or together with AdNull, (0.1 MOI) using Trizol reagent (Invitrogen, Carlsbad, CA, USA), and reverse-transcribed into a single-stranded cDNA using the Superscript TM III First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA, USA). One-hundred nanograms of cDNA, as determined by photometry at 260/280 nm, (Genequant II, Pharmacia, DuÈben-dorf, Switzerland) was used as template for amplification in a 50-ll reaction mixture, and GFP, HSPG, FGF-R1 or alpha v integrin mRNA was then quantified by real-time PCR (MJ Research, Waltham, MA, USA) with a Platinum SYBR Green qPCR SuperMix UDG Kit (Invitrogen, Carlsbad, CA, USA). To normalize each sample, the copy number of the GAPDH gene was also quantified. For copy number control standards, serial dilutions of pZac-eGFP were used. The relative target gene expression was normalized with a calibrator (hRPE cells with treatment of rAAV2-GFP only). The final result, expressed as N-fold differences in target gene expression relative to the GAPDH gene and the calibrator, was determined by the following formula: N target = 2
ÀDDCt . The primer pairs specific for transgene and rAAV2 receptors were described in Table 1 .
Determination of transgene copy number
APRE-19 cells were infected as described above and total DNA was extracted from the infected APRE-19 cells (DNA Extraction Kit, Invitrogen, Carlsbad, CA, USA) when mRNA was purified. One-hundred nanograms of DNA (determined by photometry at 260/280 nm) was added to a total of 50 ll of a reaction mixture for amplification using a Platinum SYBR Green qPCR SuperMix UDG Kit. The copy number of the GAPDH gene was used as an intrinsic control. The GFP copy numbers were then determined by real-time PCR and presented as N-fold differences to the calibrator as described above.
Animal grouping and subretinal injection
Normal adult Sprague-Dawley (SD) rats (180-200 g), BALB/c mice (18-20 g), and Royal College of Surgeons (RCS) rats (3-week old) were used in this experiment. All animals were treated, maintained, and sacrificed in accordance with the policies stated in the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the guidelines approved by national and local institutions. SD and RCS rats were anesthetized with intraperitoneal injection of 10% chloral hydrate and BALB/c mice with 0.1% sodium pentobarbital. Surgical procedures and post-surgery care were performed as described previously (Duisit et al., 2002; Zhang et al., 2008) . Briefly, eyes were gently protruded using a rubber circle and subsequently covered with 2% hydroxypropylmethylcellulose in PBS. The tip of a 1.5-cm, 28-gauge needle was inserted 1 mm posterior to the corneal limbus causing a self-sealing wound tunnel. Trans-sclera subretinal injection of 2 ll viral suspension or PBS was made by introducing a blunt 32-gauge Hamilton syringe through the sclera, vitreous into subretinal space in the superior retina. Eyes of SD rats, BALB/c mice and RCS rats were injected with rAAV2-GFP, rAAV2-LUC or rAAV2-CNTF alone or combined with AdNull, respectively. Control eyes were not injected or were injected with PBS. The doses of viral vectors included rAAV2-GFP 1 Â 10 9 vg/eye, rAAV2-Luc 1 Â 10 9 vg/ eye, rAAV2-CNTF 1 Â 10 9 vg/eye, and AdNull 1 Â 10 4 PFU/eye. Approximately 250 normal SD rats, 25 BALB/c mice and 54 130 RCS rats were used in this study.
Bioluminescence and fluorescence imaging in vivo retina
GFP fluorescence expression in the ocular fundus of live SD rats was monitored and photographed by fluorescent stereoscope (LEICA MZFLIII, Jena, Germany) on days 1, 3, 7, 14, 30, 60, 120, and 180 days post-injection. ImagePro Plus Software (Media Cybernetics, Silver Spring, MD) was used to analyze and quantify the area and mean density of GFP fluorescence. Data are presented as IOD (total area Â mean density of GFP fluorescence). Bioluminescence imaging of luciferase in the eyes of BALB/c mice was performed by the in vivo imaging system (Roper, Scientific, Trenton, NJ, USA) 1, 7, 15, 30, 120, and 300 days post-injection.
Tissue processing and HE staining
SD and RCS rats were sacrificed with an overdose intraperitoneal injection of 10% chloral hydrate 8 weeks after subretinal injection. After enucleation, eyes were fixed in 10% formaldehyde solution, embedded in paraffin, and then sectioned into 5 lm thick fragments. Sections were stained with hematoxylin and eosin to observe retinal architecture, inflammatory cell infiltration, and retinal thickening using fluorescence microscopy (ZEISS AXIOPLAN 2 imaging, Jena, Germany).
Morphometric analysis of photoreceptor layers in RCS rats
Morphometric analysis of the outer nuclear layer (ONL) in RCS retina was performed with Imagepro Plus Software. The measurements were taken in both the temporal and nasal halves of the retinas as described previously (Michon, Li, Shioura, Anderson, & Tso, 1991) . Three defined regions were selected in each hemisphere under a 5Â objective for measurements of ONL thickness. Two regions were separated by a distance of 300 lm from the ora serrata and optic nerve head, and the third was at the midpoint. Three measurements were taken for each region in five consecutive sections under a 40Â objective with a bright light. The mean of these values was used as the estimate of ONL thickness. To confirm the measurements of ONL thickness, the numbers of rows of nuclei in the vertical column of the ONL were counted at the same areas, again making multiple counts in multiple consecutive sections. The mean of these values was used as the estimate of photoreceptor nuclei rows in each half of the retina. The data were processed for statistical significance using the paired Student's t test.
Western blot analysis
APRE-19 cells (1 Â 10 5 ), infected with 10 4 MOI rAAV2-GFP only or in combination with 0.1 MOI AdNull, were collected 7 days after infection. Royal College of Surgeons (RCS) rats were decapitated 8 weeks after subretinal space injection, as described above, and the retinas were carefully dissected. hRPE cells and retinas were incubated on ice for 15 min with lysis buffer. Samples were centrifuged at 12,000 rpm for 10 min at 4°C, and the supernatants containing solubilized protein extracts were collected. Each sample was denatured for 5 min at 95°C in loading buffer. Equal amounts of 2 lg protein were then loaded for each sample in all lanes and separated on SDS-PAGE followed by transfer to a polyvinylidene fluoride (PVDF) membrane. The membrane was then incubated with either a mouse monoclonal antibody against GFP (MBL, 1:10,000) or goat polyclonal antibody against CNTF (1:2000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted in 5% milk. The probed PVDF membrane was incubated with anti-mouse or anti-goat peroxidase-linked secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and developed by ECL Western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Results
Effects of adenovirus 5 on rAAV2-mediated transgene expression in vitro
To analyze whether a lower dose of adenovirus 5 (replicationcompetent or replication-incompetent Ad5) can improve rAAV2-mediated gene expression in retinal cells, we transduced APRE-19 cells, primary cultured human RPE cells, and rat neural retinal cells with rAAV2-GFP in the presence and absence of AdNull or Ad5-TERT-E1A/E1B. We found that either AdNull or Ad5-TERT-E1A/E1B improved rAAV2-mediated gene expression in a dose-dependent manner by enhancing both the amount of GFP-positive cells and the intensity of GFP expression (Fig. 1A  and B) . The increment of GFP expression was further confirmed by Western blotting (Fig. 1C) . MOI (0.1) AdNull produced similar effects on rAAV2-mediated gene expression compared to 0.01 MOI Ad5-TERT-E1A/E1B. No apparent cellular apoptosis was detected by FACS when the titer of Ad5 was less than 10 MOI (AdNull) or 1 MOI (Ad5-TERT-E1A/E1B) in the combined transduction compared to transduction with rAAV2-GFP only (data not shown). To study whether Ad5 might exert a sustained effect on rAAV2-mediated gene expression and to assess the kinetics of the effect, we conducted an experiment in which APRE-19 cells were transduced with rAAV2-GFP, in the presence or absence of 0.1 MOI AdNull, and then harvested for FACS analysis 1, 3, 5, 7, 10 or 12 days post-infection. This revealed that earlier onset of gene expression mediated by rAAV2-GFP occurred with the assistance of AdNull. Also, the enhancement of transgene expression depended on the incubation period and required 7 days for the expression to reach a plateau. Furthermore, our results showed that GFP expression levels in rAAV2-GFP with AdNull-infected cells were more than 4-fold higher at all time points compared to rAAV2-GFP infected cells (Fig. 1D) . To examine whether the enhancement of rAAV2-mediated gene expression was due to Ad5 directly entering the cells, we transduced APRE-19 cells with a combination of rAAV2-GFP and 0.1 MOI Ad5-RFP (Fig. 1E) . Most APRE-19 cells expressing GFP did not display RFP fluorescence, and the cells expressing RFP fluorescence were not always observed with GFP fluorescence. Indeed, a very small proportion of cells expressed both GFP and RFP fluorescence at the same time.
Effects on receptor expression
To determine whether AdNull acted by enhancing the entry of rAAV2, we infected APRE-19 cells with rAAV2-GFP combined with or without 1 MOI AdNull, and then analyzed the level of fundamental receptor HSPG and co-receptors alpha v integrin and fibroblast growth factor receptor 1 (FGF-R1) at various times after infection by real-time quantitative PCR. This analysis demonstrated that AdNull modestly enhanced the mRNA levels of HSPG, alpha v integrin and FGF-R1, although the augmentation was not enough to explain the drastic increase in expression (Table 2) .
Effects on rAAV2 copy number and transgene mRNA
To investigate whether AdNull might exert its effects on gene expression at the DNA duplication or mRNA transcription level, we performed quantitative real-time PCR and RT-PCR analyses of rAAV2-mediated transgene expression in APRE-19 cells. To do so, cells were harvested 24, 72, and 120 h after transduction with rAAV2-GFP either alone or in combination with 0.1 MOI AdNull. We found that combination with AdNull resulted in more than a 4-fold increase in GFP mRNA levels (at 120 h) compared to transduction with rAAV2-GFP alone. However, AdNull did not significantly affect the copy number of the rAAV2 (Table 2 ). These data suggest that AdNull's major effect on rAAV2-mediated gene expression occurs at the level of gene transcription, and not at the DNA replication level.
Ad5-assisted enhancement and acceleration of rAAV2-mediated gene expression in retina in vivo
In the analysis using optical bioluminescence imaging of Balb/c mice, we found drastic enhancement and acceleration of luciferase gene expression in retinas with subretinal injections of rAAV2-Luc combined with AdNull, compared to subretinal injection of rAAV2-Luc only ( Fig. 2A) . Combination of AdNull substantially increased rAAV2-mediated luciferase expression at early time points postinjection and exerted a positive effect on gene expression at later time points. The fact that AdNull enhanced rAAV2-mediated gene expression in the live retina was further confirmed by fluorescent stereoscope imaging of SD retina after subretinal injection of rAAV2-GFP with or without AdNull (Fig. 2B and C) . From these results, we determined that the combination of AdNull resulted in a significant chronic increase of GFP expression. These data strongly suggest the potential utility of AdNull for improving expression levels from rAAV2-mediated gene transfer in the retina in vivo.
Ad5-assisted enhancement of photoreceptor survival in RCS rat
To assess whether subretinal administration of rAAV2-CNTF combined with a lower dosage of Ad5 could enhance the protective effect against retinal degeneration disease, we performed an experiment in which RCS rats were subjected to a subretinal injection of rAAV2-CNTF with or without AdNull. Uninjected or PBS-injected eyes were used as controls. Histological examination showed obvious preservation of photoreceptors in the rAAV2-CNTF with AdNull injected eyes, in comparison with either rAAV2-CNTF injected, (2-3 rows of photoreceptor nuclei) PBS-injected, or uninjected eyes (Fig. 3A, Supplementary Table) . Morphometric analyses revealed significant differences in the thickness of the outer nuclear layer (ONL) and the number of rows of nuclei in the ONL among the rAAV2-CNTF with Ad5-Null injected, the rAAV2-CNTF alone injected, and the PBS-injected or the non-injected eyes (P < .01) (Supplementary Table) . To verify that enhancement of photoreceptor survival was due to an increase in CNTF production in the eyes injected with rAAV2-CNTF and AdNull, we performed a Western blot analysis using a commercially available antibody to CNTF. This revealed that the combination of AdNull and rAAV2-CNTF led to a pronounced increase in CNTF expression in live rat retinas relative to simple applications of rAAV2-CNTF (Fig. 3B ).
Immune response of subretinal injection of a low dosage of AdNull
One concern was whether there were any negative effects on the retina from the combination of rAAV2-CNTF and AdNull. To evaluate this, the treatment-injected eyes of SD and RCS rats were stained with hematoxylin and eosin, and histological observations were performed. In these experiments, there was no obvious tissue damage in the retinal sections. No obvious accumulation or infiltration of inflammatory cells was observed in the host retina. These data suggested that the combination of rAAV2 and a lower dose of AdNull cannot induce a severe immune response. These results were consistent with reports from other groups which used adenovirus as a gene delivery vehicle to treat retinal degeneration (Huang, Zhang, et al., 2004; Huang, Lin, et al., 2004) .
Discussion
The results presented here indicate that a lower level of Ad5 can exert a significant enhancing and accelerating effect on rAAV2-mediated gene expression in retinal cells, and that this effect occurs principally at the transcriptional level rather than via enhanced viral entry or DNA replication. Furthermore, the relationship between Ad5 entering cells and rAAV2 transgene expression was preliminarily demonstrated by combining rAAV2-GFP and Ad-RFP infections. In the analysis with the normal SD rat, the Balb/c mouse, and the retinitis pigmentosa (RP) model of RCS rats, strong enhancement of transgene expression, as well as therapeutic effects, was confirmed in vivo.
The application of rAAV2 vectors to retinal gene therapy is limited by their relatively low transduction efficiency. Several previous studies have reported that genotoxic chemicals, such as hydroxyurea and DNA-damaging agents, including c-and UV-irradiation, increased rAAV2 transduction (Kim et al., 2005; Zhao et al., 2006) , but these treatments also produced significant cytotoxicity (Maloney et al., 2006; Yakobson, Koch, & Winocour, 1987) . Indeed, early studies have reported that several viruses can assist in AAV growth and productive replication (Ferrari et al., 1996; Fisher et al., 1996) . This fact was further confirmed by an experiment which showed that the combination of rAAV2-BMP and Ad5-BMP produces enhanced osteogenic activity in immunocompetent rats (Chen et al., 2004) . A study conducted by Borras et al. demonstrated that 4E1/E3 adenoviruses dramatically enhanced transduction of rAAV2 in human trabecular meshwork (Borras et al., 2006) . However, there has been no direct investigation of the effects of Ad5 on the rAAV2-mediated gene expression in retinal cells. In this report, we showed that low-level Ad5-enhanced and accelerated transduction by rAAV2 vectors in the retina in vitro and in vivo, with neither remarkable apoptosis nor an immune response.
Ad5 improved the rAAV2-mediated gene transfer in a dosedependent manner, regardless of conditional replication-competent (Ad5-TERT-E1A/E1B) or replication-incompetent (AdNull), and the highest enhancement was observed in retinal cells infected by rAAV2-GFP combined with either 0.1 MOI AdNull or 0.01 MOI Ad5-TERT-E1A/E1B. APRE-19 cultures exposed to 0.1 MOI AdNull were transduced at 4-to 10-fold higher rates, and roughly 3-to 5-fold increases were observed in transgene mRNA expression. Enhancement of receptor levels was modest, and the copy number The final result was expressed as N-fold differences in target gene expression relative to the GAPDH gene and the calibrator. of rAAV2 in the transduced cells was also only modestly affected by the combination of AdNull. Viewed in this light, the superior transduction induced by Ad5 was actually due to an enhancement of transgene expression principally at the transcriptional level, rather than enhanced viral entry or DNA replication. These observations were concordant with previously reported findings, which have shown that an HDAC inhibitor, a kind of chemical agent, can enhance rAAV-mediated gene expression at the mRNA level (Okada et al., 2006) . The molecular mechanism of increased rAAV-mediated gene expression in retinal cells remains to be determined. Early studies demonstrated that the enhancement of adenovirus for in vitro AAV transduction was neither facilitated by adenovirus-mediated viral uptake nor dependent on the AAV gene cassette, but was instead dependent on adenovirus gene products (Allen, Halbert, & Miller, 2000; Nayak & Pintel, 2007) . Indeed, it had been documented that the conversion of single-stranded rAAV2 genomes into doublestranded transcriptionally active forms was a rate-limiting step both in vitro and in vivo. This step could be enhanced either by co-infecting the cells with adenovirus or by introducing the E4 (orf6) gene alone (Fisher et al., 1996) . Enhancement by the E1 gene was also observed in conjunction with E4 (orf6), and expression of the orf6 from E4 in the absence of E1 accomplished a similar, but attenuated effect. In the present study, the E1 and E3 adenovirus regions of AdNull had already been deleted, and the E1A and E1B region in Ad5-TERT-E1A/E1B had been controlled by telomerase, although they both possessed the E4 (orf6) region. In this context, E4/ORF6 in AdNull or E4/ORF6 together with E1 in Ad5-TERT-E1A/ E1B might play a pivotal role in the dramatic enhancement of rAAV2-mediated transduction in retinal cells. The results from our study also suggested that the E4ORF6 gene is an essential element, but that the E1 gene can further enhance rAAV-mediated transgene expression, which is consistent with previous reports (Fisher et al., 1996) .
Interestingly, a very small proportion of APRE-19 cells infected by rAAV2-GFP combined with Ad5-RFP presented both RFP and GFP fluorescence. In fact, many cells which expressed increased GFP fluorescence did not show RFP fluorescence at all. There are two possible explanations regarding the unexpressed-RFP cells: Ad5 had not entered these cells; alternatively, the amount of Ad5 to enter the cells was too small to be observed with RFP fluorescence using the inverted fluorescence microscope. Based on the fact that less than one particle per cell Ad5-RFP had been used for combinational infection, we deduced that the former could be more reasonable. It remained to be confirmed whether these data suggested that Ad5 could influence rAAV2 transgene expression not only by physical Ad gene product presence in the rAAV transduced cells, but also by interaction between Ad infected and uninfected cells that would sensitize uninfected cells to rAAV transduction. Whether it was caused by secreted factors or direct interaction between Ad infected and uninfected cells needs to be further investigated. This result complemented and extended the previous notion regarding Ad5-enhanced AAV2 gene expression.
The findings of this study in vivo demonstrated that the combination of both rAAV2 and low-level AdNull improved rAAV2 gene transfer efficiency in the retina without causing severe immune responses in Balb/c mouse, SD and RCS rat. Previous studies had shown that the intraocular injection of Ad-CNTF or rAAV2-CNTF protected more photoreceptors than injection of recombinant CNTF (Huang, Zhang, et al., 2004; Huang, Lin, et al., 2004; Liang et al., 2001) . Nevertheless, Ad causes a higher risk of tissue immune responses and Ad-mediated transgene expression lasts for a shorter period compared to rAAV2 (Flotte, 2007) . However, a potential barrier of rAAV2 for retinal gene therapy is its relatively low transduction efficiency to some ocular cells. In this study, we found that when rAAV2-CNTF (1 Â 10 9 vg) was combined with AdNull at a dose of 1 Â 10 4 PFU, the combination actually resulted in dramatically enhanced protection of photoreceptors in RCS rats. The dose of AdNull used here was low enough to elude host defense mechanisms that were sensitive to the adenovirus, and the optimal dose range of adenovirus could be further investigated for future preclinical studies. Noticeably, the enhancement effect of Ad5 on rAAV2 gene expression could last for at least 10 months, when Ad5 was already eliminated from the retina; this mechanism should be further investigated. Our results indicated that low-level Ad5 could greatly enhance, accelerate and prolong rAAV2-mediated gene expression in the retina in vivo and in vitro. Our unpublished data showed that Ad5 could also enhance transduction efficiency in retinal cells mediated by rAAV1/2, rAAV5, and rAAV8 (data not shown). It is worth attempting when the ocular gene therapy applies to the endothelium of the retinal blood vessel, trabecular meshwork and some inner retinal cells, when rAAV-mediated transduction is weak. Therefore, the new strategy described here provided a simple and feasible method to improve retinal disease gene therapy.
